BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25916305)

  • 1. [Hotspot report of the 56th American Society of Hematology Annual Meeting:progress of treatment in chronic lymphocytic leukemia].
    Cao L; Fan L; Xu W; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):358-60. PubMed ID: 25916305
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Davids MS
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report on recent treatment progress of chronic lymphocytic leukemia in the 55th annual meeting of American Society of Hematology].
    Xia Y; Xu W; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):380-2. PubMed ID: 24759038
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in chronic lymphocytic leukemia from the 60th American Society of Hematology Annual Meeting: commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 1(1):20-23. PubMed ID: 31545308
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Hematology (ASH) meeting.
    Cheson BD
    Clin Adv Hematol Oncol; 2014 Jan; 12(1):8. PubMed ID: 25000312
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in Chronic Lymphocytic Leukemia From the 2020 American Society of Clinical Oncology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Aug; 18(8):463-464. PubMed ID: 32903245
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hotspot report of 56th American Society of Hematology Annual Meeting: Hodgkin lymphoma].
    Wang F; Fan L; Xu W; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):262-4. PubMed ID: 25854479
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Coombs CC
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):15-19. PubMed ID: 35343945
    [No Abstract]   [Full Text] [Related]  

  • 12. Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper.
    Loh KP; Christofyllakis K; Huang LW; Mims A
    J Geriatr Oncol; 2019 Mar; 10(2):186-191. PubMed ID: 30661875
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in the treatment of chronic lymphocytic leukemia from the 2013 meeting of the American Society of Hematology.
    Molica S
    Expert Rev Hematol; 2014 Apr; 7(2):187-90. PubMed ID: 24617332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of chronic lymphocytic leukemia: potential directions from ASH 2017.
    Molica S
    Expert Rev Hematol; 2018 Jun; 11(6):481-486. PubMed ID: 29791237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights from the 46 th annual meeting of the American Society of Hematology.
    Fassas A; Barlogie B; Feusner J; Kay NE; Wingard JR
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):111-6. PubMed ID: 16166978
    [No Abstract]   [Full Text] [Related]  

  • 16. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
    Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in chronic lymphocytic leukemia from the 2017 American Society of Hematology Annual Meeting: commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2018 Jan; 16 Suppl 2(1):16-19. PubMed ID: 29742092
    [No Abstract]   [Full Text] [Related]  

  • 18. 42nd Annual Meeting of American Society of Hematology. San Francisco, CA. December 1-5, 2000.
    D'Orazio AI; Gambill BD
    Clin Lymphoma; 2001 Mar; 1(4):251-6. PubMed ID: 11715982
    [No Abstract]   [Full Text] [Related]  

  • 19. Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 13(9):1-20. PubMed ID: 33843884
    [No Abstract]   [Full Text] [Related]  

  • 20. Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting: commentary.
    O'Brien SM
    Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 13(9):13-17. PubMed ID: 33843885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.